Sign In
Buy ADMA
$8.69
+0.120 (+1.40%)
At Close: Jun 23, 2026
Did You Suffer Losses in ADMA Biologics, Inc. (ADMA)? Contact Levi & Korsinsky About Securities Fraud Claims
11:50am, Friday, 27'th Mar 2026
New York, New York--(Newsfile Corp. - March 27, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into ADMA Biologics, Inc. ("ADMA Biologics, Inc.") (NASDAQ: ADMA) con
ADMA Biologics Issues Statement Refuting Unsubstantiated, Misleading and Inaccurate Allegations by Culper Research
07:00am, Friday, 27'th Mar 2026
Short seller's Characterization of ASCENIV's Competitive Position Reflects Blatant Misunderstanding of ADMA's Business and Its Role as Late-line Therapy for Patients Who are Immune Compromised and The
ADMA Biologics Hit with Securities Fraud Investigation After Stock Slides 29% Amid Channel Stuffing Claims – Investors with Losses Alerted to Contact BFA
NEW YORK--(BUSINESS WIRE)---- $ADMA #ADMA--BFA Law Launches Investigation into ADMA Biologics after Short Seller Report -- Investors Notified to Contact BFA Law.
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of ADMA Biologics, Inc
INVESTOR ALERT: Investigation of ADMA Biologics, Inc. (ADMA) Announced by Holzer & Holzer, LLC
12:45pm, Thursday, 26'th Mar 2026
ATLANTA, March 26, 2026 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether ADMA Biologics, Inc. (“ADMA” or the “Company”) (NASDAQ: ADMA) complied with federal securities laws. O
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc. - ADMA
10:00am, Thursday, 26'th Mar 2026
NEW YORK, March 26, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ADMA Biologics, Inc. ("ADMA" or the "Company") (NASDAQ: ADMA). Such investors are advised to
ADMA Biologics, Inc. (ADMA) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
09:00am, Thursday, 26'th Mar 2026
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of ADMA Biologics, Inc. (“ADMA” or the “Company”) (NASDAQ: ADMA) investors concerning the Co
Adma Biologics (ADMA) Stock Slides as Market Rises: Facts to Know Before You Trade
06:51pm, Wednesday, 25'th Mar 2026
Adma Biologics (ADMA) closed the most recent trading day at $9.63, moving 15% from the previous trading session.
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of ADMA Biologics, Inc. (“ADMA” or the “Company”) (NASDAQ: ADMA) on behalf of investors concerning the
Shareholder Alert: Ademi LLP Investigates Claims of Securities Fraud against ADMA Biologics, Inc.
04:01pm, Wednesday, 25'th Mar 2026
MILWAUKEE, March 25, 2026 /PRNewswire/ -- Ademi LLP is investigating possible securities fraud claims against ADMA (NASDAQ: ADMA). The investigation results from inaccurate statements ADMA may have ma
Short Seller Report Alleges ADMA Biologics Financial Misrepresentation
01:22pm, Wednesday, 25'th Mar 2026
• ADMA Biologics stock is testing key support levels. What's pressuring ADMA?
Down 27% in 4 Weeks, Here's Why Adma Biologics (ADMA) Looks Ripe for a Turnaround
10:35am, Wednesday, 25'th Mar 2026
The heavy selling pressure might have exhausted for Adma Biologics (ADMA) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street anal
ADMA Biologics Addresses Misleading Short-Seller Report
06:30am, Wednesday, 25'th Mar 2026
RAMSEY, N.J. and BOCA RATON, Fla., March 25, 2026 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), a U.S. based, end-to-end commercial biopharmaceutical compa
New Strong Buy Stocks for March 25th
06:01am, Wednesday, 25'th Mar 2026
EQT, BCBP, FIX, PAAS and ADMA have been added to the Zacks Rank #1 (Strong Buy) List on March 25, 2026.
